Skip to main content
DYNAVAX TECHNOLOGIES CORP logo

DYNAVAX TECHNOLOGIES CORP — Investor Relations & Filings

Ticker · DVAX ISIN · US2681582019 LEI · 549300T5URIXWDILX594 US Manufacturing
Filings indexed 1,230 across all filing types
Latest filing 2026-02-11 Major Shareholding Noti…
Country US United States of America
Listing US DVAX

About DYNAVAX TECHNOLOGIES CORP

https://www.dynavax.com/

Dynavax Technologies Corp. is a commercial-stage biopharmaceutical company focused on developing and commercializing vaccines to prevent infectious diseases. The company's core strength lies in its proprietary Toll-like Receptor (TLR) immune-modulating technology. Its lead commercial product is HEPLISAV-B, an adult hepatitis B vaccine that utilizes the company's CpG 1018 adjuvant to enhance the immune response. In addition to marketing its own vaccines, Dynavax supplies its CpG 1018 adjuvant to other companies for use in their vaccine development programs.

Recent filings

Filing Released Lang Actions
SCHEDULE 13G/A Filing
Major Shareholding Notification
2026-02-11 English
4 Filing
Director's Dealing
2026-02-11 English
4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
Director's Dealing
2026-02-10 English
4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
Director's Dealing
2026-02-10 English
4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
Director's Dealing
2026-02-10 English
4 - DYNAVAX TECHNOLOGIES CORP (0001029142) (Filer)
Director's Dealing
2026-02-10 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.